Lumicera Marks 10 Years of Improving Transparency for Specialty Drug Management
June 27 2024 - 12:55PM
Business Wire
Innovative ‘cost-plus’ model for specialty
drugs helps lower costs for ground-breaking medication while
helping patients manage their treatment
Lumicera Health Services, the first specialty pharmacy built on
a cost-plus model, is celebrating 10 years of making specialty
medication pricing more transparent and affordable. Growing from
its Madison startup roots to serve all 50 states and Puerto Rico
with seven physical locations, Lumicera is committed to helping
patients through a comprehensive care model and delivering
affordable medications.
Lumicera’s focus on high-touch patient care is the number one
driver behind its patient satisfaction and a key contributor to the
company’s sustained growth, recently achieving a place among the
Top 15 specialty pharmacies according to Drug Channels Institute.
Lumicera works directly with patients to ensure they can access the
appropriate medications, and counsels them to improve
adherence.
“Lumicera was founded by Navitus a decade ago in recognition of
the potential costs and patient care complexities for emerging
specialty drugs,” said Sharon Faust, PharmD, Senior Vice President
of Specialty Pharmacy at Lumicera. “We wanted to bring a
transparent, acquisition cost-plus model, similar to the model used
by our parent company, Navitus Health Solutions, to best help
employers take care of their employees.”
Owned by Navitus Health Solutions, a transparent 100%
pass-through pharmacy benefit manager (PBM), Lumicera is one of few
cost-plus pharmacies and is uniquely focused on specialty
medications. Dedicated experts research and negotiate best pricing
to ensure patient access to critical medications. Lumicera's
commitment extends within the industry, serving as a key dispensing
pharmacy partner for CivicaScript and their transparent pricing
model, and supporting, training and investing in the future of
pharmacy through various programs across the country.
The combination of reasonable specialty drug prices and an
emphasis on patient engagement has led to achievements
including:
- Improved Affordability: In 2023, 86% of Lumicera
patients received copay assistance, with an average 90% reduction
in copay costs. Lumicera helped secure $115 million in copay
assistance, combining cost savings with a strong focus on patient
engagement.
- High-Quality Patient Care Model: Pharmacists conduct
regular follow ups, and are encouraged to engage with patients
outside of standard workflows to ensure patient needs are truly
heard. Patients have the flexibility to use an online portal,
two-way texting, or live phone support to get their questions
answered and help improve adherence. Lumicera’s high-touch model
has resulted in an overall 97% overall patient satisfaction score,
and 98% new patient satisfaction score.
- Efficient Prescription Dispensing: Lumicera has shipped
more than one million prescriptions directly to patients.
- Comprehensive Medication Offerings and Customized Clinical
Pathways: Lumicera offers more than 300 unique medications and
customized disease specific clinical pathways designed to keep
patients on track with their therapy and ensure optimal treatment
outcomes.
- Drug Advocacy: Lumicera is an advocate for biosimilars
within the specialty pharmacy sector, launching the first landmark
drug from CivicaScript, Abiraterone, which is used with steroid
medication (Prednisone) to treat prostate cancer that has spread to
other parts of the body. Lumicera is an active member of
Transparency-Rx, a non-partisan not-for-profit coalition of
industry experts working to change drug pricing for the better and
also has also built its own partner network to help educate other
specialty pharmacies on patient care, complex conditions and
pricing.
- Centers of Excellence for Personalized Care: Lumicera
has built several Centers of Excellence which offer robust, 24/7
patient support and customized treatments with specially trained
staff, the largest being their accredited Oncology Center of
Excellence, where pharmacists are specifically trained to support
patients undergoing treatment for cancer.
About Lumicera Health Services
Lumicera Health Services is a leading specialty pharmacy
dedicated to providing superior patient care and ensuring positive
outcomes through innovative practices and strategic partnerships.
For more information, visit www.lumicera.com.
About Navitus Health Solutions
Navitus Health Solutions, LLC is a pioneering pharmacy solutions
provider that first launched a Pharmacy Benefit Manager (PBM) to
pass through 100% of negotiated drug rebates and discounts to
health plans and plan sponsors. As an alternative to traditional
PBMs that divert rebates for profit, the Navitus PBM leads the way
in driving meaningful cost savings to help make medications more
affordable. After more than 20 years, the organization now delivers
a broad range of solutions through portfolio brands and partners
including Navitus, EpiphanyRx, Lumicera, Archimedes, and
CivicaScript. Owned by SSM Health and Costco, Navitus Health
Solutions serves over 14 million lives across 800 clients including
employers, unions, government plans, payors and health systems. For
more information, please visit www.navitus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240627429680/en/
Sarah Broome Sarah.Broome@aircoverpr.com